Transplantation of a human iPSC-derived hepatocyte sheet increases survival in mice with acute liver failure
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND & AIMS: Hepatocyte transplantation is one of the most attractive approaches for the treatment of patients with liver failure. Because human induced pluripotent stem cell-derived hepatocyte-like cells (iPS-HLCs) can be produced on a large scale and generated from a patient with liver failure, they are expected to be used for hepatocyte transplantation. However, when using conventional transplantation methods, i.e., intrasplenic or portal venous infusion, it is difficult to control the engraftment efficiency and avoid unexpected engraftment in other organs because the transplanted cells are delivered into blood circulation before their liver engraftment. METHODS: In this study, to resolve these issues, we attempted to employ a cell sheet engineering technology for experimental hepatocyte transplantation. The human iPS-HLC sheets were attached onto the liver surfaces of mice with liver injury. RESULTS: This method reduced unexpected engraftment in organs other than the liver compared to that by intrasplenic transplantation. Human albumin levels in the mice with human iPS-HLC sheets were significantly higher than those in the intrasplenically-transplanted mice, suggesting the high potential for cell engraftment of the sheet transplantation procedure. In addition, human iPS-HLC sheet transplantation successfully ameliorated lethal acute liver injury induced by the infusion of carbon tetrachloride (CCl4). Moreover, we found that the hepatocyte growth factor secreted from the human iPS-HLC sheet played an important role in rescuing of mice from acute hepatic failure. CONCLUSIONS: Human iPS-HLC sheet transplantation would be a useful and reliable therapeutic approach for a patient with severe liver diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Huh, C.-G., Factor, V. M., Sánchez, A., Uchida, K., Conner, E. A., & Thorgeirsson, S. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306068101 · Cited by 750
Liver Progenitor Cells Yield Functional Hepatocytes in Response to Chronic Liver Injury in Mice
Español–Suñer, R., Carpentier, R., Van Hul, N., Legry, V., Achouri, Y., Cordi, S., Jacquemin, P., Lemaigre, F., & Leclercq, I. A. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.08.024 · Cited by 356
Wang, X., DeFrances, M. C., Dai, Y., Pediaditakis, P., Johnson, C., Bell, A., Michalopoulos, G. K., & Zarnegar, R. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00439-2 · Cited by 225
Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice
Meier, R. P. H., Mahou, R., Morel, P., Meyer, J., Montanari, E., Muller, Y. D., Christofilopoulos, P., Wandrey, C., Gonelle-Gispert, C., & Bühler, L. H. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.030 · Cited by 153
Research works printed but not linked: 33
- Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019 · DOI · Paper page
- Nagamoto, 2012, The promotion of hepatic maturation of human pluripotent stem cells in 3D co-culture using type I collagen and Swiss 3T3 cell sheets, Biomaterials, 33, 4526, 10.1016/j.biomaterials.2012.03.011 · DOI
- Takayama, 2012, Generation of metabolically functioning hepatocytes from human pluripotent stem cells by FOXA2 and HNF1alpha transduction, J Hepatol, 57, 628, 10.1016/j.jhep.2012.04.038 · DOI
- Takayama, 2013, 3D spheroid culture of hESC/hiPSC-derived hepatocyte-like cells for drug toxicity testing, Biomaterials, 34, 1781, 10.1016/j.biomaterials.2012.11.029 · DOI · Paper page
- Takayama, 2012, Efficient generation of functional hepatocytes from human embryonic stem cells and induced pluripotent stem cells by HNF4alpha transduction, Mol Ther, 20, 127, 10.1038/mt.2011.234 · DOI · Paper page
- Tachibana, 2013, Repopulation of the immunosuppressed retrorsine-treated infant rat liver with human hepatocytes, Xenotransplantation, 20, 227, 10.1111/xen.12037 · DOI
- Tateno, 2004, Near completely humanized liver in mice shows human-type metabolic responses to drugs, Am J Pathol, 165, 901, 10.1016/S0002-9440(10)63352-4 · DOI · Paper page
- Basma, 2009, Differentiation and transplantation of human embryonic stem cell-derived hepatocytes, Gastroenterology, 136, 990, 10.1053/j.gastro.2008.10.047 · DOI · Paper page
- Gupta, 1991, Permanent engraftment and function of hepatocytes delivered to the liver: implications for gene therapy and liver repopulation, Hepatology, 14, 144, 10.1002/hep.1840140124 · DOI · Paper page
- Gupta, 1999, Entry and integration of transplanted hepatocytes in rat liver plates occur by disruption of hepatic sinusoidal endothelium, Hepatology, 29, 509, 10.1002/hep.510290213 · DOI · Paper page
- Liu, 2011, In vivo liver regeneration potential of human induced pluripotent stem cells from diverse origins, Sci Transl Med, 3, 82ra39, 10.1126/scitranslmed.3002376 · DOI · Paper page
- Woo, 2012, Direct and indirect contribution of human embryonic stem cell-derived hepatocyte-like cells to liver repair in mice, Gastroenterology, 142, 602, 10.1053/j.gastro.2011.11.030 · DOI
- Kawamura, 2013, Enhanced survival of transplanted human induced pluripotent stem cell-derived cardiomyocytes by the combination of cell sheets with the pedicled omental flap technique in a porcine heart, Circulation, 128, S87, 10.1161/CIRCULATIONAHA.112.000366 · DOI · Paper page
- Ohashi, 2007, Engineering functional two- and three-dimensional liver systems in vivo using hepatic tissue sheets, Nat Med, 13, 880, 10.1038/nm1576 · DOI · Paper page
- Tatsumi, 2013, A novel cell-sheet technology that achieves durable factor VIII delivery in a mouse model of hemophilia A, PLoS One, 8, 10.1371/journal.pone.0083280 · DOI
- Ohashi, 2012, Liver tissue engineering utilizing hepatocytes propagated in mouse livers in vivo, Cell Transplant, 21, 429, 10.3727/096368911X605330 · DOI
- Higgins, 1931, Experimental pathology of the liver, Arch Pathol, 12, 186
- Grisham, 1962, A morphologic study of deoxyribonucleic acid synthesis and cell proliferation in regenerating rat liver; autoradiography with thymidine-H3, Cancer Res, 22, 842
- Kondoh, 2006, Longer preservation of cardiac performance by sheet-shaped myoblast implantation in dilated cardiomyopathic hamsters, Cardiovasc Res, 69, 466, 10.1016/j.cardiores.2005.11.005 · DOI · Paper page
- Sekine, 2011, Cardiac cell sheet transplantation improves damaged heart function via superior cell survival in comparison with dissociated cell injection, Tissue Eng Part A, 17, 2973, 10.1089/ten.tea.2010.0659 · DOI · Paper page
- Elloumi-Hannachi, 2010, Cell sheet engineering: a unique nanotechnology for scaffold-free tissue reconstruction with clinical applications in regenerative medicine, J Intern Med, 267, 54, 10.1111/j.1365-2796.2009.02185.x · DOI · Paper page
- Takayama, 2014, Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes, Proc Natl Acad Sci U S A, 111, 16772, 10.1073/pnas.1413481111 · DOI · Paper page
- Mazzetti, 2004, Lycopersicon esculentum lectin: an effective and versatile endothelial marker of normal and tumoral blood vessels in the central nervous system, Eur J Histochem, 48, 423, 10.4081/916 · DOI · Paper page
- Moslem, 2013, Therapeutic potential of human induced pluripotent stem cell-derived mesenchymal stem cells in mice with lethal fulminant hepatic failure, Cell Transplant, 22, 1785, 10.3727/096368912X662462 · DOI
- Frisch, 1999, Evidence for a function of death-receptor-related, death-domain-containing proteins in anoikis, Curr Biol, 9, 1047, 10.1016/S0960-9822(99)80455-2 · DOI · Paper page
- Rytomaa, 1999, Involvement of FADD and caspase-8 signalling in detachment-induced apoptosis, Curr Biol, 9, 1043, 10.1016/S0960-9822(99)80454-0 · DOI · Paper page
- Zvibel, 2002, Anoikis: roadblock to cell transplantation?, Cell Transplant, 11, 621, 10.3727/000000002783985404 · DOI · Paper page
- Sharma, 2012, Intrasplenic transplantation of isolated adult rat hepatocytes: sex-reversal and/or suppression of the major constituent isoforms of cytochrome P450, Toxicol Pathol, 40, 83, 10.1177/0192623311425061 · DOI
- Ponder, 1991, Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation, Proc Natl Acad Sci U S A, 88, 1217, 10.1073/pnas.88.4.1217 · DOI · Paper page
- Jin, 2011, Hepatocyte growth factor promotes liver regeneration induced by transfusion of bone marrow mononuclear cells in a murine acute liver failure model, J Hepatobiliary Pancreat Surg, 18, 397, 10.1007/s00534-010-0343-8 · doi:10.1007/s00534-010-0343-8
- Asano, 2007, Hepatocyte growth factor promotes remodeling of murine liver fibrosis, accelerating recruitment of bone marrow-derived cells into the liver, Hepatol Res, 37, 1080, 10.1111/j.1872-034X.2007.00206.x · DOI
- Parekkadan, 2007, Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells, Biochem Biophys Res Commun, 363, 247, 10.1016/j.bbrc.2007.05.150 · DOI · Paper page
- Appasamy, 1993, Hepatocyte growth factor, blood clearance, organ uptake, and biliary excretion in normal and partially hepatectomized rats, Lab Invest, 68, 270
Cited by
Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications
Cerneckis, J., Cai, H., & Shi, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01809-0 · Cited by 452
Multi-lineage human iPSC-derived platforms for disease modeling and drug discovery
Sharma, A., Sances, S., Workman, M. J., & Svendsen, C. N. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.02.011 · Cited by 296
“, 2018) and hepatocytes to metabolize drugs and generate albumin (Liu et al., 2011; Nagamoto et al., 2016; Pettinato et al., 2019).”
BackgroundJin, Y., Zhang, J., Xu, Y., Yi, K., Li, F., Zhou, H., Wang, H., Chan, H. F., Lao, Y.-H., Lv, S., et al. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.05.001 · Cited by 55
“As most cells can be removed by macrophages or phagocytes after intrasplenic transplantation [41,43], and an inflammatory environment in the liver also impairs the viability of transplanted cells [31,44], Cu NZs@PLGA nanofibers integrated with dECM hydrogels were applied for in situ delivery of HLCs.”
BackgroundLi, G., He, J., Shi, J., Li, X., Liu, L., Ge, X., Chen, W., Jia, J., Wang, J., Yin, M., et al. (2025) · Gut · doi:10.1136/gutjnl-2024-333885 · Cited by 41
Reversal of established liver fibrosis by IC-2-engineered mesenchymal stem cell sheets
Itaba, N., Kono, Y., Watanabe, K., Yokobata, T., Oka, H., Osaki, M., Kakuta, H., Morimoto, M., & Shiota, G. (2019) · Scientific Reports · doi:10.1038/s41598-019-43298-0 · Cited by 29
Alternative Cell Sources for Liver Parenchyma Repopulation: Where Do We Stand?
Tricot, T., De Boeck, J., & Verfaillie, C. (2020) · Cells · doi:10.3390/cells9030566 · Cited by 20
Udagawa, D., Nagata, S., Yagi, H., Nishi, K., Morisaku, T., Adachi, S., Nakano, Y., Tanaka, M., Hori, S., Hasegawa, Y., et al. (2024) · Cell Transplantation · doi:10.1177/09636897241253700 · Cited by 11
“Many studies have demonstrated the use of orthotopic HCT coupled with biomaterials, such as cell sheets and patch grafts, as another approach to HCT 18,19 .”
BackgroundRegulated differentiation of stem cells into an artificial 3D liver as a transplantable source
Chen, F., Wang, H., & Xiao, J. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2019.0022n · Cited by 8
Metadata
- Authors
- Nagamoto, Y., Takayama, K., Ohashi, K., Okamoto, R., Sakurai, F., Tachibana, M., Kawabata, K., & Mizuguchi, H.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2016-05
- Volume
- 64
- Issue
- 5
- Pages
- 1068-1075
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2291107594
- Cited by
- 177
- References
- 4
- FWCI
- 18.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.